Filing metadata

Accession number
0001209191-17-053199
Form type
Form 3
Filer
Eiger BioPharmaceuticals, Inc.
CIK
CIK 1305253
Filed
Sep 18, 2017
Reporting period
Sep 15, 2017
Description
Initial ownership

Explore SEC Filings Hub